Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (101-110 of 217) with videos related to

Pageof 22
Sort By:
American Journal of Cancer Research|December 10, 2019
BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screeningJie Ding, Shaofang Wu, Chen Zhang, et al.
International Journal of Cancer|May 18, 2010
Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastomaHo-Shin Gwak, Takashi Shingu, Vaibhav Chumbalkar, et al.
The Journal of Biological Chemistry|July 19, 2003
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascadesYiling Lu, Qinghua Yu, Jue Hui Liu, et al.
Neuro-Oncology|March 19, 2013
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysisYong-Wan Kim, Dimpy Koul, Se Hoon Kim, et al.
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Cancer Gene Therapy|January 15, 2005
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitizationCharles Conrad, C Ryan Miller, Yongjie Ji, et al.
Journal of Neuro-Oncology|March 1, 2005
PAX6 suppresses growth of human glioblastoma cellsYi-Hong Zhou, Xiaosong Wu, Fang Tan, et al.
British Journal of Cancer|August 13, 2009
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiformeM D Groves, V K Puduvalli, M R Gilbert, et al.
Journal of the National Cancer Institute|October 18, 2001
Gamma-radiation sensitivity and risk of gliomaM L Bondy, L E Wang, R El-Zein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
Pageof 22

Showing results (101-110 of 217) with videos related to

Sort By:
Pageof 22
American Journal of Cancer Research|December 10, 2019
BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screeningJie Ding, Shaofang Wu, Chen Zhang, et al.
International Journal of Cancer|May 18, 2010
Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastomaHo-Shin Gwak, Takashi Shingu, Vaibhav Chumbalkar, et al.
The Journal of Biological Chemistry|July 19, 2003
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascadesYiling Lu, Qinghua Yu, Jue Hui Liu, et al.
Neuro-Oncology|March 19, 2013
Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysisYong-Wan Kim, Dimpy Koul, Se Hoon Kim, et al.
Journal of Neuro-Oncology|March 10, 2009
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanomaMorris D Groves, Kenneth R Hess, Vinay K Puduvalli, et al.
Cancer Gene Therapy|January 15, 2005
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitizationCharles Conrad, C Ryan Miller, Yongjie Ji, et al.
Journal of Neuro-Oncology|March 1, 2005
PAX6 suppresses growth of human glioblastoma cellsYi-Hong Zhou, Xiaosong Wu, Fang Tan, et al.
British Journal of Cancer|August 13, 2009
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiformeM D Groves, V K Puduvalli, M R Gilbert, et al.
Journal of the National Cancer Institute|October 18, 2001
Gamma-radiation sensitivity and risk of gliomaM L Bondy, L E Wang, R El-Zein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecanCandelaria Gomez-Manzano, Marta M Alonso, W K Alfred Yung, et al.
Pageof 22